Who owns Revelation Biosciences Inc?
- Ticker: REVB
- CUSIP Number: 76135l804
Tip: Access positions for across all investors
Analyze quarterly positions in Revelation Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revelation Biosciences stock
Who bought or sold Revelation Biosciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 211k | $217k | 112% | Jun 2026 |
|
| Citadel Advisors | 39k | $40k | 100% | Jun 2026 |
|
| Geode Capital Management | 17k | $18k | -60% | Jun 2026 |
|
| Hrt Financial | 17k | $17k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 13k | $14k | 0% | Jun 2026 |
|
| Tower Research Capital | 6.5k | $6.7k | 60% | Jun 2026 |
|
| Royal Bank of Canada | 747.00 | $1.0k | 0% | Jun 2026 |
|
| SBI Securities | 344.00 | $354.010400 | 0% | Jun 2026 |
|
| Barclays | 168.00 | $173.006400 | 100% | Jun 2026 |
|
| Bnp Paribas Investment Partners | 9.00 | $9.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 0% | Jun 2026 |
|
Who sold out of Revelation Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Mar 2026 | 323k | $388k |
| XTX Topco | Mar 2026 | 11k | $14k |
| UBS Group | Mar 2026 | 4.1k | $4.9k |